跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Comirnaty Original/Omicron B.A.4-5 - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Comirnaty Original/Omicron B.A.4-5
Approved
STANDARD
Comirnaty Original/Omicron B.A.4-5
Pfizer, Inc.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
c6eb31c68ed47817
Company
Pfizer, Inc.
Type
Standard
Approval Details
Approval Id
c6eb31c68ed47817
Drug Approval Philippines Name
Comirnaty Original/Omicron B.A.4-5
Product Name
Comirnaty Original/Omicron B.A.4-5
Registration Number
BR-1444
Brand Name
Comirnaty Original/Omicron B.A.4-5
Generic Name
Tozinameran/Famtozinameran
Dosage Form
Dispersion For Injection (IM)
Dosage Strength
15 mcg/15 mcg/0.3mL
Manufacturer
Pfizer, Inc.
Importer
Pfizer Manufacturing Belgium NV
Distributor
Pfizer Manufacturing Belgium NV
Company Detail Path
/organization/pfizer-inc-pleasant-prairie-wisconsin-united-states
Importer Detail Path
/organization/pfizer-manufacturing-belgium
Distributor Detail Path
/organization/pfizer-manufacturing-belgium
Issuance Date
08 June 2023
Expiry Date
08 June 2028
Pharmacologic Category
Vaccines
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
c6eb31c68ed47817
Type
Standard
Back to Philippines FDA Approvals